Mayer Davidson, MD, and Vivian Fonseca, MD, provide their perspectives on the clinical importance of 10 posters presented at the 77th Scientific Sessions of the American Diabetes Association from June 9-13, 2017. Drs. Davidson and Fonseca summarize the latest research developments on key mechanisms in the pathogenesis of type 2 diabetes mellitus and how they are modified by basal and prandial insulins and glucagon-like peptide-1 receptor agonists. In addition, Drs. Davidson and Fonseca provide their insight into the clinical implications of clinical trial results regarding the efficacy, safety, and tolerability of recently available and investigational injectable medications for diabetes mellitus.
Proceed at your own pace and in any order. Each study perspective is about 5 minutes.
2.50 AMA PRA Category 1 Credits™.
2.50 ANCC Contact Hours
|Opens:||July 31, 2017|
|Expires:||July 30, 2018|
Primary Care Physicians
Other Health Care Providers